The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global End Stage Renal Disease Treatment Market Research Report 2025

Global End Stage Renal Disease Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1685585

No of Pages : 99

Ask Your Query
Synopsis
End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.
The global End Stage Renal Disease Treatment market was valued at US$ 55330 million in 2023 and is anticipated to reach US$ 76120 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
Fresenius is one of the most important global key players of the end stage renal disease treatment, holds about 20% of shares of the global end stage renal disease treatment market, other key players include DaVita, Baxter, etc. North America is the largest market, occupied for about 40 percent, followed by the Asia Pacific. In terms of type, hemodialysis is the largest segment, with a share of about 70%, and in terms of application, the kidney dialysis centers segment holds a share of over 60 percent.
This report aims to provide a comprehensive presentation of the global market for End Stage Renal Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding End Stage Renal Disease Treatment.
Report Scope
The End Stage Renal Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global End Stage Renal Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the End Stage Renal Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Nikkiso
WEGO
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
Segment by Type
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation
Segment by Application
Hospitals
Kidney Dialysis Centers
At Homes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of End Stage Renal Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global End Stage Renal Disease Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hemodialysis
1.2.3 Peritoneal Dialysis
1.2.4 Kidney Transplantation
1.3 Market by Application
1.3.1 Global End Stage Renal Disease Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Kidney Dialysis Centers
1.3.4 At Homes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global End Stage Renal Disease Treatment Market Perspective (2019-2030)
2.2 End Stage Renal Disease Treatment Growth Trends by Region
2.2.1 Global End Stage Renal Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 End Stage Renal Disease Treatment Historic Market Size by Region (2019-2024)
2.2.3 End Stage Renal Disease Treatment Forecasted Market Size by Region (2025-2030)
2.3 End Stage Renal Disease Treatment Market Dynamics
2.3.1 End Stage Renal Disease Treatment Industry Trends
2.3.2 End Stage Renal Disease Treatment Market Drivers
2.3.3 End Stage Renal Disease Treatment Market Challenges
2.3.4 End Stage Renal Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top End Stage Renal Disease Treatment Players by Revenue
3.1.1 Global Top End Stage Renal Disease Treatment Players by Revenue (2019-2024)
3.1.2 Global End Stage Renal Disease Treatment Revenue Market Share by Players (2019-2024)
3.2 Global End Stage Renal Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by End Stage Renal Disease Treatment Revenue
3.4 Global End Stage Renal Disease Treatment Market Concentration Ratio
3.4.1 Global End Stage Renal Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by End Stage Renal Disease Treatment Revenue in 2023
3.5 End Stage Renal Disease Treatment Key Players Head office and Area Served
3.6 Key Players End Stage Renal Disease Treatment Product Solution and Service
3.7 Date of Enter into End Stage Renal Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 End Stage Renal Disease Treatment Breakdown Data by Type
4.1 Global End Stage Renal Disease Treatment Historic Market Size by Type (2019-2024)
4.2 Global End Stage Renal Disease Treatment Forecasted Market Size by Type (2025-2030)
5 End Stage Renal Disease Treatment Breakdown Data by Application
5.1 Global End Stage Renal Disease Treatment Historic Market Size by Application (2019-2024)
5.2 Global End Stage Renal Disease Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America End Stage Renal Disease Treatment Market Size (2019-2030)
6.2 North America End Stage Renal Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America End Stage Renal Disease Treatment Market Size by Country (2019-2024)
6.4 North America End Stage Renal Disease Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe End Stage Renal Disease Treatment Market Size (2019-2030)
7.2 Europe End Stage Renal Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe End Stage Renal Disease Treatment Market Size by Country (2019-2024)
7.4 Europe End Stage Renal Disease Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific End Stage Renal Disease Treatment Market Size (2019-2030)
8.2 Asia-Pacific End Stage Renal Disease Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific End Stage Renal Disease Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific End Stage Renal Disease Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America End Stage Renal Disease Treatment Market Size (2019-2030)
9.2 Latin America End Stage Renal Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America End Stage Renal Disease Treatment Market Size by Country (2019-2024)
9.4 Latin America End Stage Renal Disease Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa End Stage Renal Disease Treatment Market Size (2019-2030)
10.2 Middle East & Africa End Stage Renal Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa End Stage Renal Disease Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa End Stage Renal Disease Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fresenius
11.1.1 Fresenius Company Detail
11.1.2 Fresenius Business Overview
11.1.3 Fresenius End Stage Renal Disease Treatment Introduction
11.1.4 Fresenius Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.1.5 Fresenius Recent Development
11.2 DaVita
11.2.1 DaVita Company Detail
11.2.2 DaVita Business Overview
11.2.3 DaVita End Stage Renal Disease Treatment Introduction
11.2.4 DaVita Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.2.5 DaVita Recent Development
11.3 Baxter
11.3.1 Baxter Company Detail
11.3.2 Baxter Business Overview
11.3.3 Baxter End Stage Renal Disease Treatment Introduction
11.3.4 Baxter Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.3.5 Baxter Recent Development
11.4 Nipro
11.4.1 Nipro Company Detail
11.4.2 Nipro Business Overview
11.4.3 Nipro End Stage Renal Disease Treatment Introduction
11.4.4 Nipro Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.4.5 Nipro Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Detail
11.5.2 B. Braun Business Overview
11.5.3 B. Braun End Stage Renal Disease Treatment Introduction
11.5.4 B. Braun Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.5.5 B. Braun Recent Development
11.6 Asahi Kasei
11.6.1 Asahi Kasei Company Detail
11.6.2 Asahi Kasei Business Overview
11.6.3 Asahi Kasei End Stage Renal Disease Treatment Introduction
11.6.4 Asahi Kasei Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.6.5 Asahi Kasei Recent Development
11.7 Nikkiso
11.7.1 Nikkiso Company Detail
11.7.2 Nikkiso Business Overview
11.7.3 Nikkiso End Stage Renal Disease Treatment Introduction
11.7.4 Nikkiso Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.7.5 Nikkiso Recent Development
11.8 WEGO
11.8.1 WEGO Company Detail
11.8.2 WEGO Business Overview
11.8.3 WEGO End Stage Renal Disease Treatment Introduction
11.8.4 WEGO Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.8.5 WEGO Recent Development
11.9 Newsol
11.9.1 Newsol Company Detail
11.9.2 Newsol Business Overview
11.9.3 Newsol End Stage Renal Disease Treatment Introduction
11.9.4 Newsol Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.9.5 Newsol Recent Development
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Detail
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic End Stage Renal Disease Treatment Introduction
11.10.4 Mayo Clinic Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.10.5 Mayo Clinic Recent Development
11.11 Guangdong Biolight
11.11.1 Guangdong Biolight Company Detail
11.11.2 Guangdong Biolight Business Overview
11.11.3 Guangdong Biolight End Stage Renal Disease Treatment Introduction
11.11.4 Guangdong Biolight Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.11.5 Guangdong Biolight Recent Development
11.12 Medtronic
11.12.1 Medtronic Company Detail
11.12.2 Medtronic Business Overview
11.12.3 Medtronic End Stage Renal Disease Treatment Introduction
11.12.4 Medtronic Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.12.5 Medtronic Recent Development
11.13 Sanxin Medtec
11.13.1 Sanxin Medtec Company Detail
11.13.2 Sanxin Medtec Business Overview
11.13.3 Sanxin Medtec End Stage Renal Disease Treatment Introduction
11.13.4 Sanxin Medtec Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.13.5 Sanxin Medtec Recent Development
11.14 Jafron Biomedical
11.14.1 Jafron Biomedical Company Detail
11.14.2 Jafron Biomedical Business Overview
11.14.3 Jafron Biomedical End Stage Renal Disease Treatment Introduction
11.14.4 Jafron Biomedical Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.14.5 Jafron Biomedical Recent Development
11.15 SWS Hemodialysis Care
11.15.1 SWS Hemodialysis Care Company Detail
11.15.2 SWS Hemodialysis Care Business Overview
11.15.3 SWS Hemodialysis Care End Stage Renal Disease Treatment Introduction
11.15.4 SWS Hemodialysis Care Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.15.5 SWS Hemodialysis Care Recent Development
11.16 Tianyi Medical
11.16.1 Tianyi Medical Company Detail
11.16.2 Tianyi Medical Business Overview
11.16.3 Tianyi Medical End Stage Renal Disease Treatment Introduction
11.16.4 Tianyi Medical Revenue in End Stage Renal Disease Treatment Business (2019-2024)
11.16.5 Tianyi Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock